Brain zaps aim to revive emotion and drive in schizophrenia

NCT ID NCT07559084

Recruiting now Symptom relief Sponsor: Shanghai Mental Health Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new type of transcranial magnetic stimulation (TMS) that targets three brain areas at once to help with negative symptoms of schizophrenia, like lack of motivation, emotion, or social interest. Researchers will enroll 64 people with first-episode schizophrenia to see if this multi-target approach is safe and reduces these symptoms better than standard care. Participants will receive the TMS treatment while continuing their usual medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: repetitive transcranial magnetic stimulation (rTMS) device
What this could lead to: If it works, this could offer a new, non-drug way to reduce negative symptoms of schizophrenia, such as social withdrawal and low motivation.
What could go wrong: This is an early, small trial (64 people) testing a new targeting approach. It may not show clear benefit, and results may not apply to everyone with schizophrenia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

schizophrenia schizophrenia 1

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCHIZOPHRENIA 1 (DISORDER)

Contacts and locations

Locations

Shanghai Mental Health Center
RECRUITING

Shanghai, Shanghai Municipality, 200030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.